Assistant Professor John Jewett, Ph.D., in the Department of Chemistry and Biochemistry, received asset development funding for an underwater adhesive he invented. Image credit: Paul Tumarkin/Tech Launch Arizona.
Monday, May 16, 2016

UA faculty perform over $600 million in research each year, and often develop new inventions. TLA, via its Asset Development Program, puts resources toward preparing these unpolished inventions for the market.

University of Arizona I-Squared Awards Event Honors Impact and Innovation in Technology Commercialization  (Photo credit: Paul Tumarkin/Tech Launch Arizona)
Tuesday, April 26, 2016

On April 25, 2016, TLA held its third annual awards event. The I-Squared Awards for Innovation and Impact honored those whose work directly affects the quality of life for people in Tucson, across Arizona and throughout the world.

UA Research Professor Minying Cai, Ph.D., and Professor Victor Hruby, Ph.D., of the Hruby Peptide Group in the Department of Chemistry and Biochemistry of the UA College of Science (Photo credit: Tech Launch Arizona)
Wednesday, April 20, 2016

Akhu Therapeutics has licensed a UA technology that is targeted to allow doctors to relieve the symptoms of acute depression in a fraction of the time required for current therapies.

New Snakebite Treatment Under Development at UA College of Medicine – Tucson
Tuesday, April 12, 2016

TLA is working with College of Medicine researchers on bringing a new snakebite treatment to market that may serve as a “bridge” to buy time until medical care is available.

Withaferin A, a prodrug being used to develop treatments for neurodegenerative disease, is derived from the Winter Cherry, shown here. Startup company Yumanity Therapeutics, Inc., is commercializing the prodrug. Image credit: Leslie Gunantilaka.
Wednesday, April 6, 2016

In 2015 the College of Agriculture and Life Sciences tripled the number of executed license and option agreements, launched three start-up companies, and had a record year in IP income.

Wednesday, April 6, 2016

TLA recently earned a designation as an I-Corps Site. Now, teams need help defining and protecting their intellectual property. The UA College of Law IP Clinic is stepping up to help. 

This composite image shows the withaferin A structure overlaying the Winter Cherry in the greenhouse. Image credit: Paul Tumarkin/Tech Launch Arizona
Friday, March 25, 2016

Startup company Yumanity Therapeutics has licensed a UA-invented prodrug and its analogues to develop treatments for neurodegenerative diseases like Alzheimer’s, Parkinson’s and ALS that affect over 55 million people.

TLA Mentors-in-Residence Mike Sember (left) and Bruce Burgess (right) join in the weekly "round table" discussion of new UA technologies and the opportunities they bring. (Photo credit: Paul Tumarkin/Tech Launch Arizona)
Monday, March 21, 2016

It takes years of experience to gain the know-how to successfully get a high-tech company off the ground. With its Mentors-in-Residence program, TLA is bringing in proven experts to help start the newest high-tech UA startups on the path to success. 

UA Startup Metropia to Help Tucson Festival of Books Attendees Arrive & Park
Tuesday, March 8, 2016

Started one year ago, UA startup Metropia will be working with the Tucson Festival of Books to help alleviate traffic congestion and help attendees get to and from their destinations.

Eric Smith, TLA Commercialization Network Manager. Photo credit: Jacob Chinn
Monday, February 29, 2016

As the newest member of the TLA Business Development team, Eric Smith works with the office's Licensing Manager and Business Intelligence groups to manage and expand TLA's 1,400-member expert network, and implement strategies to leverage the collective knowledge of that network to more effectively commercialize technologies invented at the UA.